Health
Peru authorizes resumption of clinical trials of Sinopharm vaccine – Macau Business
The Peruvian government has authorized the resumption of clinical trials of a COVID-19 vaccine developed by the China National Pharmaceutical Group
The Peruvian government has authorized the resumption of clinical trials of a COVID-19 vaccine developed by the China National Pharmaceutical Group, or Sinopharm, after an “adverse event” in one of the volunteers was “clarified,” said Health Minister Pilar Mazzetti.
“Finally we have scheduled a meeting with Sinopharm, having solved the problem of the suspension of the clinical trial we had in the country. The situation has already been clarified and that suspension has been lifted today,” Mazzetti…
Continue Reading
